Sei Investments Co. cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 6.6% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 284,770 shares of the semiconductor company’s stock after selling 20,194 shares during the period. Sei Investments Co. owned approximately 0.18% of Synopsys worth $145,996,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of SNPS. Symphony Financial Ltd. Co. boosted its stake in shares of Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares during the period. HBW Advisory Services LLC lifted its holdings in Synopsys by 494.9% in the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after buying an additional 3,004 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after buying an additional 4,815 shares during the last quarter. Westbourne Investments Inc. acquired a new stake in shares of Synopsys during the second quarter valued at about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Synopsys by 1.7% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after acquiring an additional 2,991 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Up 2.1%
NASDAQ:SNPS opened at $475.83 on Thursday. The stock has a 50 day moving average of $435.91 and a 200-day moving average of $504.68. The firm has a market capitalization of $88.39 billion, a PE ratio of 37.35, a price-to-earnings-growth ratio of 5.78 and a beta of 1.16. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the company. Rosenblatt Securities raised Synopsys from a “neutral” rating to a “buy” rating and reduced their price target for the company from $605.00 to $560.00 in a report on Tuesday. Stifel Nicolaus reduced their target price on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. KeyCorp set a $600.00 price target on shares of Synopsys in a research report on Thursday. The Goldman Sachs Group dropped their price target on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $556.13.
Check Out Our Latest Stock Report on SNPS
Insiders Place Their Bets
In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the transaction, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.62% of the stock is owned by company insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Consumer Staples Stocks, Explained
- GameStop Looks Broken: Here’s Why GME Could Crash in 2026
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Market Momentum: 3 Stocks Poised for Major Breakouts
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
